期刊文献+

口服抗凝药物治疗的心房颤动患者出血与血小板计数之间的相关性分析 被引量:4

Analysis of the relationship between bleeding and platelet count in atrial fibrillation patients with treatment of oral anticoagulants
下载PDF
导出
摘要 目的探讨口服抗凝药物治疗的心房颤动患者出血与血小板计数之间相关性以及对出血的影响因素进行分析。方法采用病例对照研究的方法,收集从2010-2019年9月期间在新疆医科大学第一附属医院住院治疗的心房颤动患者共2226名,根据患者有无出血症状分为出血组(n=301)和无出血组(n=1925)。收集基本信息、合并症、血液指标等,分析两组患者的基线数据特征,采用Logistic回归分析研究出血与血小板计数之间的关系及影响因素。结果两组患者在性别构成、年龄分布及合并症、血液指标等方面的差异无统计学意义(P均>0.05),两组的HAS-BLED评分差异有统计学意义(P<0.05)。心房颤动患者服用拜阿司匹灵、华法林、达比加群酯、利伐沙班等不同药物,在皮下出血、呕血、咯血、黑便及其他出血等方面的差异无统计学意义(P均>0.05)。性别、年龄分组、合并高血压、心力衰竭、糖尿病、血栓性疾病、肝功能异常、肾功能异常、CHA2DS2-VASc及HAS-BLED评分与出血事件有相关关系(P<0.05)。结论基于目前现有的资料,不能得出口服抗凝药物治疗的房颤患者出血与血小板计数之间有相关关系。性别、年龄分组、合并症、CHA2DS2-VASc及HAS-BLED评分是出血事件发生的影响因素。 Objective To explore the correlation between bleeding and platelet count in patients with atrial fibrillation treated by oral anticoagulants and analyze the influencing factors of bleeding.Methods A case-control study was used to collect 2226 patients with atrial fibrillation who were hospitalized in the First Affiliated Hospital of Xinjiang Medical University from September 2010 to September 2019.The patients were divided into bleeding group(n=301)and non bleeding group(n=1925)according to whether they had bleeding symptoms.The basic information,complications and blood indexes were collected,the baseline data characteristics of the two groups were analyzed,and the relationship between bleeding and platelet count and the influencing factors were studied by logistic regression analysis.Results There was no significant difference between the two groups in gender composition,age distribution,comorbidities and blood index(P>0.05),and there was significant difference in HAS-BLED score between the two groups(P<0.05).There was no significant difference in subcutaneous hemorrhage,hematemesis,hemoptysis,black stool and other bleeding in patients with atrial fibrillation(P>0.05).Gender,age group,hypertension,heart failure,diabetes,thrombotic disease,liver function abnormality,renal function abnormality,CHA2DS2-VASc and HAS-BLED scores were correlated with bleeding events(P<0.05).Conclusion Based on the current data,it is not possible to conclude that there is a correlation between blood loss and platelet count in patients with AF treated with oral anticoagulants.Sex,age group,comorbidity,CHA2DS2-VASc and HAS-BLED scores were the influencing factors of bleeding events.
作者 尼加提·尼亚孜 艾力菲热·帕尔哈提 刘帅 迪拉热·阿迪 马依彤 Paerhati;LIU Shuai;Dilare Adi;MA Yitong(The First Clinical Medical College and the First Affiliated Hospital,Urumqi 830054,China;Department of Cardiology,First Affiliated Hospital of Xinjiang Medical University,Urumqi 830054,China)
出处 《新疆医科大学学报》 CAS 2020年第2期140-144,148,共6页 Journal of Xinjiang Medical University
基金 国家自然科学基金(81873490)
关键词 心房颤动 抗凝药物治疗 出血 CHA2DS2-VASc评分 HAS-BLED评分 atrial fibrillation anticoagulants drug therapy bleeding CHA2DS2-VASc score HAS-BLED score
  • 相关文献

参考文献4

二级参考文献31

  • 1胡大一,孙艺红.心房颤动的流行病学和治疗现状[J].中华全科医师杂志,2006,5(1):5-7. 被引量:85
  • 2胡大一,张鹤萍,孙艺红,姜立清.华法林与阿司匹林预防非瓣膜性心房颤动患者血栓栓塞的随机对照研究[J].中华心血管病杂志,2006,34(4):295-298. 被引量:162
  • 3Krahn AID, Manfreda J,Tate RB, et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study[J]. Am J Med, 1995,98(5): 476-484.
  • 4Cowan C,Healicon R,Robson I, et aI,The use of anticoagula- tion in management of atrial fibrillation among general practices in England[J]. Heart,2013,99(16) : 1166-1172.
  • 5Zhou ZQ , Hu DY,Chen J,et al. An epidemiologicaI survey of atrial fibrillation in China[J]. Chin J Intern Med, 2004,43 (7) : 491-494.
  • 6Chinese Society of Cardiology of Chinese Medical Association, The Chinese Society of Gerontology Cardio-cerebrovoscular Disease Professional Committee. Rhythm of the Biomedical Engineering Branch of China. Atrial fibrillation anti- coagulation China expert consensus[J]. Chin J Intern Med, 2012, 51(11) :916-921.
  • 7Pisters R Lane DA, Nieuwlaat R, et al. Anovel user friendly score (HAS-BLED)to assess 1-year risk of major bleeding pa- tients with atrial fibrillation: the Euro heartsurvey[J]. Chest, 2010,138(5) : 1093-1100.
  • 8Kim JS, She F, Jongnarangsin K, et al. Dabigatranvs warfarin for radiofrequency catheter ablation of atrial fibrillation[J]. Heart Rhythm,2013,10(4) :483-489.
  • 9Levi M, Peuter OR, Kamphuisen PW. Management strategies for optimal control of anticoagulation patients with atrial fi- brillation[J]. Semin Thromb Hemost,2009,35(6):560-567.
  • 10Liu B, Liu LZ,Xuan J, et al. Treatment patterns associated with stroke prevention in patients with atrial {ibrillation in three major cities in the People's Republic of china[J]. Int J Gen Med, 2013, 19(7):29-35.

共引文献39

同被引文献67

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部